0001838716 2023-01-01 2023-12-31 0001838716 dei:BusinessContactMember 2023-01-01 2023-12-31 0001838716 GNTA:AmericanDepositarySharesEachAmericanDepositaryShareRepresentingOneOrdinaryShareMember 2023-01-01 2023-12-31 0001838716 GNTA:OrdinarySharesNoParValueMember 2023-01-01 2023-12-31 0001838716 2023-12-31 iso4217:USD shares iso4217:USD shares true FY 0001838716 20-F/A false true 2023-12-31 --12-31 2023 false false 001-41115 Genenta Science S.p.A. Via Olgettina No. 58 20132 Milan IT Via Olgettina No. 58 20132 Milan IT Pierluigi Paracchi +39-02-2643-4681 pierluigi.paracchi@genenta.com American depositary shares (each American depositary share representing one ordinary share) GNTA NASDAQ Ordinary shares, no par value NASDAQ 18216958 No No Yes Yes Non-accelerated Filer true false false Dannible & McKee, LLP 528 Syracuse, New York On March 29, 2024, Genenta Science S.p.A. (the “Company”) filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “Original Filing”). This Amendment No. 1 (the “Amendment”) amends the Original Filing solely to file the consent of the Company’s independent registered public accounting firm, Dannible & McKee, LLP (the “Auditor Consent”), which was inadvertently omitted in the Original Filing.